Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Maroun

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2002
First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorinJ Cassidy, C Twelves, E Van Cutsem, et al.
Current Oncology (Toronto, Ont.)|August 19, 2016
Corrigendum: Eastern Canadian Gastrointestinal Cancer Consensus Conference 2014E Tsvetkova, S Sud, N Aucoin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trialW Scheithauer, J McKendrick, S Begbie, et al.
Current Oncology (Toronto, Ont.)|October 5, 2011
Progression-free survival as a clinical trial endpoint in advanced renal cell carcinomaS J Hotte, G A Bjarnason, D Y C Heng, et al.
Current Oncology (Toronto, Ont.)|October 5, 2011
Progression-free survival in advanced ovarian cancer: a Canadian review and expert panel perspectiveA M Oza, V Castonguay, D Tsoref, et al.
International Journal of Molecular Sciences|February 26, 2025
zDHHC-Mediated S-Palmitoylation in Skin Health and Its Targeting as a Treatment PerspectiveFarah A Abdulrahman, King A Benford, Gregory T Lin, et al.
Current Oncology (Toronto, Ont.)|July 24, 2010
Eastern Canadian Colorectal Cancer Consensus Conference: setting the limits of resectable diseaseM Vickers, B Samson, B Colwell, et al.
Current Oncology (Toronto, Ont.)|March 12, 2016
Eastern Canadian Colorectal Cancer Consensus Conference 2013: emerging therapies in the treatment of pancreatic, rectal, and colorectal cancersT Di Valentin, T Asmis, J Asselah, et al.
Current Oncology (Toronto, Ont.)|October 25, 2013
Eastern Canadian Colorectal Cancer Consensus Conference: standards of care for the treatment of patients with rectal, pancreatic, and gastrointestinal stromal tumours and pancreatic neuroendocrine tumoursT Di Valentin, J Biagi, S Bourque, et al.
Current Oncology (Toronto, Ont.)|June 7, 2012
Eastern Canadian colorectal cancer consensus conference: application of new modalities of staging and treatment of gastrointestinal cancersT Di Valentin, Y Alam, A Ali Alsharm, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2002
First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorinJ Cassidy, C Twelves, E Van Cutsem, et al.
Current Oncology (Toronto, Ont.)|August 19, 2016
Corrigendum: Eastern Canadian Gastrointestinal Cancer Consensus Conference 2014E Tsvetkova, S Sud, N Aucoin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trialW Scheithauer, J McKendrick, S Begbie, et al.
Current Oncology (Toronto, Ont.)|October 5, 2011
Progression-free survival as a clinical trial endpoint in advanced renal cell carcinomaS J Hotte, G A Bjarnason, D Y C Heng, et al.
Current Oncology (Toronto, Ont.)|October 5, 2011
Progression-free survival in advanced ovarian cancer: a Canadian review and expert panel perspectiveA M Oza, V Castonguay, D Tsoref, et al.
International Journal of Molecular Sciences|February 26, 2025
zDHHC-Mediated S-Palmitoylation in Skin Health and Its Targeting as a Treatment PerspectiveFarah A Abdulrahman, King A Benford, Gregory T Lin, et al.
Current Oncology (Toronto, Ont.)|July 24, 2010
Eastern Canadian Colorectal Cancer Consensus Conference: setting the limits of resectable diseaseM Vickers, B Samson, B Colwell, et al.
Current Oncology (Toronto, Ont.)|March 12, 2016
Eastern Canadian Colorectal Cancer Consensus Conference 2013: emerging therapies in the treatment of pancreatic, rectal, and colorectal cancersT Di Valentin, T Asmis, J Asselah, et al.
Current Oncology (Toronto, Ont.)|October 25, 2013
Eastern Canadian Colorectal Cancer Consensus Conference: standards of care for the treatment of patients with rectal, pancreatic, and gastrointestinal stromal tumours and pancreatic neuroendocrine tumoursT Di Valentin, J Biagi, S Bourque, et al.
Current Oncology (Toronto, Ont.)|June 7, 2012
Eastern Canadian colorectal cancer consensus conference: application of new modalities of staging and treatment of gastrointestinal cancersT Di Valentin, Y Alam, A Ali Alsharm, et al.
Pageof 5